Sickle Cell Disease-Pathophysiology and Treatment

Current Problems in Pediatric and Adolescent Health Care

Volumn 36, Issue 10, 2006, Pages 346-376

  Redding Lallinger, Rupa ^a   Knoll, Christine ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BOSENTAN; BRONCHODILATING AGENT; CEFTRIAXONE; CEPHALOSPORIN; CODEINE; DEXAMETHASONE; DIETHYLSTILBESTROL; DIPHENHYDRAMINE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROXYUREA; HYDROXYZINE; IBUPROFEN; LAXATIVE; MACROLIDE; NAPROXEN; NARCOTIC ANALGESIC AGENT; NIMODIPINE; NITRIC OXIDE DONOR; OPIATE DERIVATIVE; OXYCODONE; PARACETAMOL; PENICILLIN DERIVATIVE; PERCOCET; PLACEBO; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; PSEUDOEPHEDRINE; UNINDEXED DRUG; VANCOMYCIN;

ACUTE CHEST SYNDROME; AIRWAY CONSTRICTION; ARTICLE; ARTIFICIAL VENTILATION; AVASCULAR NECROSIS; BACTERIAL INFECTION; BACTERIAL STRAIN; BILIARY TRACT DISEASE; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CHILD DEVELOPMENT; CHILD GROWTH; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CHOLECYSTECTOMY; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; DECOMPRESSION SURGERY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG SAFETY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ERYTHROCYTE APLASIA; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPOVENTILATION; INCIDENCE; INJECTION SITE PAIN; LEUKOPENIA; LIVER DISEASE; NOMENCLATURE; PAIN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PENICILLIN ALLERGY; PLASMAPHERESIS; PREVALENCE; PRIAPISM; PSYCHOTHERAPY; PULMONARY HYPERTENSION; RADIODIAGNOSIS; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SICKLE CELL ANEMIA; SPLENECTOMY; SPLENOMEGALY; TREATMENT OUTCOME; TREATMENT PLANNING;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE FACTORS; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANEMIA, SICKLE CELL; ANTIBIOTIC PROPHYLAXIS; ANTISICKLING AGENTS; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMANS; HYDROXYUREA; IBUPROFEN; IMMUNIZATION; INFANT; INFANT, NEWBORN; MALE; MORPHINE; PAIN; PAIN MEASUREMENT; PENICILLINS; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 33749993757     PISSN: 15385442     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cppeds.2006.07.002     Document Type: Article

References (202)

1. Quinn C.T., Rogers Z.R., and Buchanan G.R. Survival of children with sickle cell disease. Blood 103 11 (2004) 4023-4027
2. Walters M.C., Storb R., Patience M., Leisenring W., Taylor T., Sanders J.E., et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 95 6 (2000) 1918-1924
3. Parise L.V., and Telen M.J. Erythrocyte adhesion in sickle cell disease. Curr Hematol Rep 2 2 (2003) 102-108
4. Okpala I. Leukocyte adhesion and the pathophysiology of sickle cell disease. Curr Opin Hematol 13 1 (2006) 40-44
5. Osarogiagbon U.R., Choong S., Belcher J.D., Vercellotti G.M., Paller M.S., and Hebbel R.P. Reperfusion injury pathophysiology in sickle transgenic mice. Blood 96 (2000) 314-320
6. Ataga K.I., and Orringer E.P. Hypercoagulability in sickle cell disease: a curious paradox. Am J Med 115 9 (2003) 721-728
7. Norris C.F., Smith-Whitley K., and McGowan K.L. Positive blood cultures in sickle cell disease: time to positivity and clinical outcome. J Pediatr Hematol Oncol 25 5 (2003) 390-395
8. Barrett-Connor E. Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine (Baltimore) 50 2 (1971) 97-112
9. Powars D., Overturf G., and Turner E. Is there an increased risk of Haemophilus influenzae septicemia in children with sickle cell anemia?. Pediatrics 71 6 (1983) 927-931
10. Wright J., Thomas P., and Serjeant G.R. Septicemia caused by Salmonella infection: an overlooked complication of sickle cell disease. J Pediatr 130 3 (1997) 394-399
11. Gill F.M., Sleeper L.A., Weiner S.J., Brown A.K., Bellevue R., Grover R., et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood 86 2 (1995) 776-783
12. Vichinsky E.P., Neumayr L.D., Earles A.N., Williams R., Lennette E.T., Dean D., et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 342 25 (2000) 1855-1865
13. Atkins B.L., Price E.H., Tillyer L., Novelli V., and Evans J. Salmonella osteomyelitis in sickle cell disease children in the east end of London. J Infect 34 2 (1997) 133-138
14. Burnett M.W., Bass J.W., and Cook B.A. Etiology of osteomyelitis complicating sickle cell disease. Pediatrics 101 2 (1998) 296-297
15. Thomas A.N., Pattison C., and Serjeant G.R. Causes of death in sickle-cell disease in Jamaica. Br Med J (Clin Res Ed) 285 6342 (1982) 633-635
16. Rogers D.W., Clarke J.M., Cupidore L., Ramlal A.M., Sparke B.R., and Serjeant G.R. Early deaths in Jamaican children with sickle cell disease. BMJ 1 6126 (1978) 1515-1516
17. Powars D.R., Chan L.S., Hiti A., Ramicone E., and Johnson C. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore) 84 6 (2005) 363-376
18. Pearson H.A., Spencer R.P., and Cornelius E.A. Functional asplenia in sickle-cell anemia. N Engl J Med 281 17 (1969) 923-926
19. Pearson H.A., Gallagher D., Chilcote R., Sullivan E., Wilimas J., Espeland M., et al. Developmental pattern of splenic dysfunction in sickle cell disorders. Pediatrics 76 3 (1985) 392-397
20. Emond A.M., Morais P., Venugopal S., Carpenter R.G., and Serjeant G.R. Role of splenectomy in homozygous sickle cell disease in childhood. Lancet 1 8368 (1984) 88-91
21. Wright J.G., Hambleton I.R., Thomas P.W., Duncan N.D., Venugopal S., and Serjeant G.R. Postsplenectomy course in homozygous sickle cell disease. J Pediatr 134 3 (1999) 304-309
22. Wilimas J.A., Flynn P.M., Harris S., Day S.W., Smith R., Chesney P.J., et al. A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease. N Engl J Med 329 7 (1993) 472-476
23. Skaggs D.L., Kim S.K., Greene N.W., Harris D., and Miller J.H. Differentiation between bone infarction and acute osteomyelitis in children with sickle-cell disease with use of sequential radionuclide bone-marrow and bone scans. J Bone Joint Surg Am 83 12 (2001) 1810-1813
24. Almeida A., and Roberts I. Bone involvement in sickle cell disease. Br J Haematol 129 4 (2005) 482-490
25. Lonergan G.J., Cline D.B., and Abbondanzo S.L. Sickle cell anemia. Radiographics 21 4 (2001) 971-994
26. Schmit P., and Glorion C. Osteomyelitis in infants and children. Eur Radiol 14 Suppl 4 (2004) L44-L54
27. Frush D.P., Heyneman L.E., Ware R.E., and Bissett III G.S. MR features of soft-tissue abnormalities due to acute marrow infarction in five children with sickle cell disease. AJR Am J Roentgenol 173 4 (1999) 989-993
28. Umans H., Haramati N., and Flusser G. The diagnostic role of gadolinium enhanced MRI in distinguishing between acute medullary bone infarct and osteomyelitis. Magn Reson Imaging 18 3 (2000) 255-262
29. Wierenga K.J., Hambleton I.R., and Lewis N.A. Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study. Lancet 357 9257 (2001) 680-683
30. Gaston M.H., Verter J.I., Woods G., Pegelow C., Kelleher J., Presbury G., et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 314 25 (1986) 1593-1599
31. Adamkiewicz T.V., Sarnaik S., Buchanan G.R., Iyer R.V., Miller S.T., Pegelow C.H., et al. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr 143 4 (2003) 438-444
32. Zarkowsky H.S., Gallagher D., Gill F.M., Wang W.C., Falletta J.M., Lande W.M., et al. Bacteremia in sickle hemoglobinopathies. J Pediatr 109 4 (1986) 579-585
33. Rogers Z.R., and Buchanan G.R. Bacteremia in children with sickle hemoglobin C disease and sickle beta(+)-thalassemia: is prophylactic penicillin necessary?. J Pediatr 127 3 (1995) 348-354
34. Lane P.A., O'Connell J.L., Lear J.L., Rogers Z.R., Woods G.M., Hassell K.L., et al. Functional asplenia in hemoglobin SC disease. Blood 85 8 (1995) 2238-2244
35. Sprinkle R.H., Cole T., Smith S., and Buchanan G.R. Acute chest syndrome in children with sickle cell disease. A retrospective analysis of 100 hospitalized cases. Am J Pediatr Hematol Oncol 8 2 (1986) 105-110
36. Scott-Conner C.E., and Brunson C.D. The pathophysiology of the sickle hemoglobinopathies and implications for perioperative management. Am J Surg 168 3 (1994) 268-274
37. Koshy M., Weiner S.J., Miller S.T., Sleeper L.A., Vichinsky E., Brown A.K., et al. Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases. Blood 86 10 (1995) 3676-3684
38. Vichinsky E., Williams R., Das M., Earles A.N., Lewis N., Adler A., et al. Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood 83 11 (1994) 3107-3112
39. Gelfand M.J., Daya S.A., Rucknagel D.L., Kalinyak K.A., and Paltiel H.J. Simultaneous occurrence of rib infarction and pulmonary infiltrates in sickle cell disease patients with acute chest syndrome. J Nucl Med 34 4 (1993) 614-618
40. Rucknagel D.L. The role of rib infarcts in the acute chest syndrome of sickle cell diseases. Pediatr Pathol Mol Med 20 2 (2001) 137-154
41. Vichinsky E.P., Neumayr L.D., Haberkern C., Earles A.N., Eckman J., Koshy M., et al. The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group. Am J Hematol 62 3 (1999) 129-138
42. Vichinsky E.P., Styles L.A., Colangelo L.H., Wright E.C., Castro O., and Nickerson B. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood 89 5 (1997) 1787-1792
43. Vichinsky E.P., Haberkern C.M., Neumayr L., Earles A.N., Black D., Koshy M., et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med 333 4 (1995) 206-213
44. Bellet P.S., Kalinyak K.A., Shukla R., Gelfand M.J., and Rucknagel D.L. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med 333 11 (1995) 699-703
45. Nordness M.E., Lynn J., Zacharisen M.C., Scott P.J., and Kelly K.J. Asthma is a risk factor for acute chest syndrome and cerebral vascular accidents in children with sickle cell disease. Clin Mol Allergy 3 1 (2005) 2
46. Bryant R. Asthma in the pediatric sickle cell patient with acute chest syndrome. J Pediatr Health Care 19 3 (2005) 157-162
47. Knight-Madden J.M., Forrester T.S., Lewis N.A., and Greenough A. Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax 60 3 (2005) 206-210
48. Boyd J.H., Moinuddin A., Strunk R.C., and DeBaun M.R. Asthma and acute chest in sickle-cell disease. Pediatr Pulmonol 38 3 (2004) 229-232
49. Boyd J.H., Macklin E.A., Strunk R.C., and DeBaun M.R. Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood (2006) May 11
50. Boyd J.H., Macklin E.A., Strunk R.C., and DeBaun M.R. Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood (2006) May 11
51. Castro O., Brambilla D.J., Thorington B., Reindorf C.A., Scott R.B., Gillette P., et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 84 2 (1994) 643-649
52. Mallouh A.A., and Asha M. Beneficial effect of blood transfusion in children with sickle cell chest syndrome. Am J Dis Child 142 2 (1988) 178-182
53. Wayne A.S., Kevy S.V., and Nathan D.G. Transfusion management of sickle cell disease. Blood 81 5 (1993) 1109-1123
54. Lanzkowsky P., Shende A., Karayalcin G., Kim Y.J., and Aballi A.J. Partial exchange transfusion in sickle cell anemia. Use in children with serious complications. Am J Dis Child 132 12 (1978) 1206-1208
55. Bernini J.C., Rogers Z.R., Sandler E.S., Reisch J.S., Quinn C.T., and Buchanan G.R. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 92 9 (1998) 3082-3089
56. Griffin T.C., McIntire D., and Buchanan G.R. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. N Engl J Med 330 11 (1994) 733-737
57. Atz A.M., and Wessel D.L. Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology 87 4 (1997) 988-990
58. Gladwin M.T., and Schechter A.N. Nitric oxide therapy in sickle cell disease. Semin Hematol 38 4 (2001) 333-342
59. Charache S., Terrin M.L., Moore R.D., et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 332 20 (1995) 1317-1322
60. Jayabose S., Tugal O., Sandoval C., Patel P., Puder D., Lin T., et al. Clinical and hematologic effects of hydroxyurea in children with sickle cell anemia. J Pediatr 129 4 (1996) 559-565
61. Koren A., Segal-Kupershmit D., Zalman L., Levin C., Abu H.M., Palmor H., et al. Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia. Pediatr Hematol Oncol 16 3 (1999) 221-232
62. Rogers Z.R. Hydroxyurea therapy for diverse pediatric populations with sickle cell disease. Semin Hematol 34 3 Suppl 3 (1997) 42-47
63. Hankins J., Jeng M., Harris S., Li C.S., Liu T., and Wang W. Chronic transfusion therapy for children with sickle cell disease and recurrent acute chest syndrome. J Pediatr Hematol Oncol 27 3 (2005) 158-161
64. Miller S.T., Wright E., Abboud M., Berman B., Files B., Scher C.D., et al. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr 139 6 (2001) 785-789
65. Platt O.S., Brambilla D.J., Rosse W.F., Milner P.F., Castro O., Steinberg M.H., et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330 23 (1994) 1639-1644
66. Steinberg M.H., Barton F., Castro O., Pegelow C.H., Ballas S.K., Kutlar A., et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 289 13 (2003) 1645-1651
67. Beyer J.E., Simmons L.E., Woods G.M., and Woods P.M. A chronology of pain and comfort in children with sickle cell disease. Arch Pediatr Adolesc Med 153 9 (1999) 913-920
68. Jacob E., Beyer J.E., Miaskowski C., Savedra M., Treadwell M., and Styles L. Are there phases to the vaso-occlusive painful episode in sickle cell disease?. J Pain Symptom Manage 29 4 (2005) 392-400
69. Fitzgerald M., and Howard R. The neurobiologic basis of pediatric pain. In: Schechter N., Berde C., and Yaster M. (Eds). Pain in infants, children, and adolescents. 2nd Edition (2003), Lippincott Williams & Wilkins, Philadelphia, PA 19-42
70. Ballas S.K., and Smith E.D. Red blood cell changes during the evolution of the sickle cell painful crisis. Blood 79 8 (1992) 2154-2163
71. Murray N., and May A. Painful crises in sickle cell disease-patients' perspectives. BMJ 297 6646 (1988) 452-454
72. Jacob E., Beyer J.E., Miaskowski C., Savedra M., Treadwell M., and Styles L. Are there phases to the vaso-occlusive painful episode in sickle cell disease?. J Pain Symptom Manage 29 4 (2005) 392-400
73. Akinola N.O., Stevens S.M., Franklin I.M., Nash G.B., and Stuart J. Rheological changes in the prodromal and established phases of sickle cell vaso-occlusive crisis. Br J Haematol 81 4 (1992) 598-602
74. Ballas S.K. The acute painful episode. In: Ballas S.K. (Ed). Sickle cell pain (1998), IASP Press, Seattle, WA 51-89 Vol. 11 ed
75. Stevens M.C., Padwick M., and Serjeant G.R. Observations on the natural history of dactylitis in homozygous sickle cell disease. Clin Pediatr (Phila) 20 5 (1981) 311-317
76. Foucan L., Ekouevi D., Etienne-Julan M., Salmi L.R., and Diara J.P. Early onset dactylitis associated with the occurrence of severe events in children with sickle cell anaemia. The Paediatric Cohort of Guadeloupe (1984-99). Paediatr Perinat Epidemiol 20 1 (2006) 59-66
77. Miller S.T., Sleeper L.A., Pegelow C.H., Enos L.E., Wang W.C., Weiner S.J., et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 342 2 (2000) 83-89
78. Platt O.S., Thorington B.D., Brambilla D.J., Milner P.F., Rosse W.F., Vichinsky E., et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 325 1 (1991) 11-16
79. Dampier C., Ely E., Eggleston B., Brodecki D., and O'neal P. Physical and cognitive-behavioral activities used in the home management of sickle pain: a daily diary study in children and adolescents. Pediatr Blood Cancer 43 6 (2004) 674-678
80. Gil K.M., Carson J.W., Sedway J.A., Porter L.S., Schaeffer J.J., and Orringer E. Follow-up of coping skills training in adults with sickle cell disease: analysis of daily pain and coping practice diaries. Health Psychol 19 1 (2000) 85-90
81. Shapiro B.S., Dinges D.F., Orne E.C., Bauer N., Reilly L.B., Whitehouse W.G., et al. Home management of sickle cell-related pain in children and adolescents: natural history and impact on school attendance. Pain 61 1 (1995) 139-144
82. Platt O.S., Thorington B.D., Brambilla D.J., Milner P.F., Rosse W.F., Vichinsky E., et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 325 1 (1991) 11-16
83. Dampier C., Ely B., Brodecki D., and O'Neal P. Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports. J Pain 3 6 (2002) 461-470
84. Platt O.S., Thorington B.D., Brambilla D.J., Milner P.F., Rosse W.F., Vichinsky E., et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 325 1 (1991) 11-16
85. Armstrong F.D., Pegelow C., Gonzalez J.C., and Martinez A. Impact of children's sickle cell disease history on nurse and physician ratings of pain and medication decisions. J Pediatr Psychol 17 (1992) 651-664
86. Dampier C., and Shapiro B. Management of pain in sickle cell disease. In: Schechter A.N., Berde C., and Yaster M. (Eds). Pain in infants, children, and adolescents. 2nd Edition (2003), Lippincott Williams & Wilkins, Philadelphia, PA 489-516
87. American Pain Society. Guideline for the management of acute and chronic pain in sickle cell disease. 1st Edition (1999)
88. Beyer J.E., and Simmons L.E. Home treatment of pain for children and adolescents with sickle cell disease. Pain Manag Nurs 5 3 (2004) 126-135
89. Dampier C., Ely B., Brodecki D., and O'neal P. Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports. J Pain 3 6 (2002) 461-470
90. Gil K.M., Anthony K.K., Carson J.W., Redding-Lallinger R., Daeschner C.W., and Ware R.E. Daily coping practice predicts treatment effects in children with sickle cell disease. J Pediatr Psychol 26 3 (2001) 163-173
91. Hines P.C., Zen Q., Burney S.N., Shea D.A., Ataga K.I., Orringer E.P., et al. Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion. Blood 101 8 (2003) 3281-3287
92. Griffin T.C., McIntire D., and Buchanan G.R. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. N Engl J Med 330 11 (1994) 733-737
93. Russell M.O., Goldberg H.I., Hodson A., Kim H.C., Halus J., Reivich M., et al. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 63 1 (1984) 162-169
94. Rothman S.M., Fulling K.H., and Nelson J.S. Sickle cell anemia and central nervous system infarction: a neuropathological study. Ann Neurol 20 6 (1986) 684-690
95. Stockman J.A., Nigro M.A., Mishkin M.M., and Oski F.A. Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med 287 17 (1972) 846-849
96. Kirkham F.J., and DeBaun M.R. Stroke in children with sickle cell disease. Curr Treat Options Neurol 6 5 (2004) 357-375
97. Buchanan G.R., DeBaun M.R., Quinn C.T., and Steinberg M.H. Sickle cell disease. Hematology (Am Soc Hematol Educ Program) (2004) 35-47
98. Pavlakis S.G., Bello J., Prohovnik I., Sutton M., Ince C., Mohr J.P., et al. Brain infarction in sickle cell anemia: magnetic resonance imaging correlates. Ann Neurol 23 2 (1988) 125-130
99. Miller S.T., Macklin E.A., Pegelow C.H., Kinney T.R., Sleeper L.A., Bello J.A., et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr 139 3 (2001) 385-390
100. Moser F.G., Miller S.T., Bello J.A., Pegelow C.H., Zimmerman R.A., Wang W.C., et al. The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol 17 5 (1996) 965-972
101. Kinney T.R., Sleeper L.A., Wang W.C., Zimmerman R.A., Pegelow C.H., Ohene-Frempong K., et al. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics 103 3 (1999) 640-645
102. Powars D.R. Natural history of sickle cell disease-the first ten years. Semin Hematol 12 3 (1975) 267-285
103. Adams R.J. Sickle cell disease and stroke. J Child Neurol 10 2 (1995) 75-76
104. Ohene-Frempong K. Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations. Semin Hematol 28 3 (1991) 213-219
105. Powars D., Chan L.S., and Schroeder W.A. The variable expression of sickle cell disease is genetically determined. Semin Hematol 27 4 (1990) 360-376
106. Balkaran B., Char G., Morris J.S., Thomas P.W., Serjeant B.E., and Serjeant G.R. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 120 3 (1992) 360-366
107. Ohene-Frempong K., Weiner S.J., Sleeper L.A., Miller S.T., Embury S., Moohr J.W., et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91 1 (1998) 288-294
108. NIH. The management of sickle cell disease. 4th Edition (2002), NIH, Bethesda, MD
109. Scothorn D.J., Price C., Schwartz D., Terrill C., Buchanan G.R., Shurney W., et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 140 3 (2002) 348-354
110. Adams R.J., McKie V.C., Brambilla D., Carl E., Gallagher D., Nichols F.T., et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials 19 1 (1998) 110-129
111. Wilimas J., Goff J.R., Anderson Jr. H.R., Langston J.W., and Thompson E. Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. J Pediatr 96 2 (1980) 205-208
112. Lusher J.M., Haghighat H., and Khalifa A.S. A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction. Am J Hematol 1 2 (1976) 265-273
113. Powars D., Wilson B., Imbus C., Pegelow C., and Allen J. The natural history of stroke in sickle cell disease. Am J Med 65 3 (1978) 461-471
114. Russell M.O., Goldberg H.I., Reis L., Friedman S., Slater R., Reivich M., et al. Transfusion therapy for cerebrovascular abnormalities in sickle cell disease. J Pediatr 88 3 (1976) 382-387
115. Sarnaik S., Soorya D., Kim J., Ravindranath Y., and Lusher J. Periodic transfusions for sickle cell anemia and CNS infarction. Am J Dis Child 133 12 (1979) 1254-1257
116. Pegelow C.H., Adams R.J., McKie V., Abboud M., Berman B., Miller S.T., et al. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 126 6 (1995) 896-899
117. Okpala I. New therapies for sickle cell disease. Hematol Oncol Clin North Am 19 (2005) 975-987
118. Singer S.T., Quirolo K., Nishi K., Hackney-Stephens E., Evans C., and Vichinsky E.P. Erythrocytapheresis for chronically transfused children with sickle cell disease: an effective method for maintaining a low hemoglobin S level and reducing iron overload. J Clin Apheresis 14 3 (1999) 122-125
119. Rosse W.F., Gallagher D., Kinney T.R., Castro O., Dosik H., Moohr J., et al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 76 7 (1990) 1431-1437
120. Schreiber G.B., Busch M.P., Kleinman S.H., and Korelitz J.J. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 334 26 (1996) 1685-1690
121. Hassan M., Hasan S., Giday S., Alamgir L., Banks A., Frederick W., et al. Hepatitis C virus in sickle cell disease. J Natl Med Assoc 95 10 (2003) 939-942
122. Wang W.C., Kovnar E.H., Tonkin I.L., Mulhern R.K., Langston J.W., Day S.W., et al. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 118 3 (1991) 377-382
123. Cohen A.R., Martin M.B., Silber J.H., Kim H.C., Ohene-Frempong K., and Schwartz E. A modified transfusion program for prevention of stroke in sickle cell disease. Blood 79 7 (1992) 1657-1661
124. Miller S.T., Jensen D., and Rao S.P. Less intensive long-term transfusion therapy for sickle cell anemia and cerebrovascular accident. J Pediatr 120 1 (1992) 54-57
125. Ware R.E., Zimmerman S.A., Sylvestre P.B., Mortier N.A., Davis J.S., Treem W.R., et al. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. J Pediatr 145 3 (2004) 346-352
126. Ware R.E., Zimmerman S.A., and Schultz W.H. Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease. Blood 94 9 (1999) 3022-3026
127. Yerys B.E., White D.A., Salorio C.F., McKinstry R., Moinuddin A., and DeBaun M. Memory strategy training in children with cerebral infarcts related to sickle cell disease. J Pediatr Hematol Oncol 25 6 (2003) 495-498
128. Cohen M.J., Branch W.B., McKie V.C., and Adams R.J. Neuropsychological impairment in children with sickle cell anemia and cerebrovascular accidents. Clin Pediatr (Phila) 33 9 (1994) 517-524
129. Craft S., Schatz J., Glauser T.A., Lee B., and DeBaun M.R. Neuropsychologic effects of stroke in children with sickle cell anemia. J Pediatr 123 5 (1993) 712-717
130. Armstrong F.D., Thompson Jr. R.J., Wang W., Zimmerman R., Pegelow C.H., Miller S., et al. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics 97 6 Pt. 1 (1996) 864-870
131. Kratovil T., Bulas D., Driscoll M.C., Speller-Brown B., McCarter R., and Minniti C.P. Hydroxyurea therapy lowers TCD velocities in children with sickle cell disease. Pediatr Blood Cancer (2006) March 8
132. Fullerton H.J., Adams R.J., Zhao S., and Johnston S.C. Declining stroke rates in Californian children with sickle cell disease. Blood 104 2 (2004) 336-339
133. Pegelow C.H., Macklin E.A., Moser F.G., Wang W.C., Bello J.A., Miller S.T., et al. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 99 8 (2002) 3014-3018
134. Topley J.M., Rogers D.W., Stevens M.C., and Serjeant G.R. Acute splenic sequestration and hypersplenism in the first five years in homozygous sickle cell disease. Arch Dis Child 56 10 (1981) 765-769
135. Emond A.M., Collis R., Darvill D., Higgs D.R., Maude G.H., and Serjeant G.R. Acute splenic sequestration in homozygous sickle cell disease: natural history and management. J Pediatr 107 2 (1985) 201-206
136. Seeler R.A., and Shwiaki M.Z. Acute splenic sequestration crises (ASSC) in young children with sickle cell anemia. Clinical observations in 20 episodes in 14 children. Clin Pediatr (Phila) 11 12 (1972) 701-704
137. Mills M.L. Life-threatening complications of sickle cell disease in children. JAMA 254 11 (1985) 1487-1491
138. Pappo A., and Buchanan G.R. Acute splenic sequestration in a 2-month-old infant with sickle cell anemia. Pediatrics 84 3 (1989) 578-579
139. Mallouh AA, Qudah A. Acute splenic sequestration together with aplastic crisis caused by human parvovirus B19 in patients with sickle cell disease. J Pediatr 193;122(4):593-5.
140. Powell R.W., Levine G.L., Yang Y.M., and Mankad V.N. Acute splenic sequestration crisis in sickle cell disease: early detection and treatment. J Pediatr Surg 27 2 (1992) 215-218
141. Pearson H.A. Sickle cell diseases: diagnosis and management in infancy and childhood. Pediatr Rev 9 4 (1987) 121-130
142. Kinney T.R., Ware R.E., Schultz W.H., and Filston H.C. Long-term management of splenic sequestration in children with sickle cell disease. J Pediatr 117 2 Pt. 1 (1990) 194-199
143. Koduri P.R., and Nathan S. Acute splenic sequestration crisis in adults with hemoglobin S-C disease: a report of nine cases. Ann Hematol 85 4 (2006) 239-243
144. Aslam A.F., Aslam A.K., and Dipillo F. Fatal splenic sequestration crisis with multiorgan failure in an adult woman with sickle cell-beta+ thalassemia. Am J Med Sci 329 3 (2005) 141-143 2005
145. Aquino V.M., Norvell J.M., and Buchanan G.R. Acute splenic complications in children with sickle cell-hemoglobin C disease. J Pediatr 130 6 (1997) 961-965
146. van R.F., Balsitis M., and French E.A. Fatal splenic sequestration crisis in adult sickle cell-beta thalassaemia. Postgrad Med J 67 792 (1991) 907-908
147. Hutchins K.D., Ballas S.K., Phatak D., and Natarajan G.A. Sudden unexpected death in a patient with splenic sequestration and sickle cell-beta+-thalassemia syndrome. J Forensic Sci 46 2 (2001) 412-414
148. Serjeant G.R., Serjeant B.E., Thomas P.W., Anderson M.J., Patou G., and Pattison J.R. Human parvovirus infection in homozygous sickle cell disease. Lancet 341 8855 (1993) 1237-1240
149. Smith-Whitley K., Zhao H., Hodinka R.L., Kwiatkowski J., Cecil R., Cecil T., Cnaan A., and Ohene-Frempong K. Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood 103 2 (2004) 422-427
150. Goldstein A.R., Anderson M.J., and Serjeant G.R. Parvovirus associated aplastic crisis in homozygous sickle cell disease. Arch Dis Child 62 6 (1987) 585-588
151. Brown K.E., Young N.S., Alving B.M., and Barbosa L.H. Parvovirus B19: implications for transfusion medicine. Summary of a workshop. Transfusion 41 1 (2001) 130-135
152. Eichhorn R.F., Buurke E.J., Blok P., Berends M.J., and Jansen C.L. Sickle cell-like crisis and bone marrow necrosis associated with parvovirus B19 infection and heterozygosity for haemoglobins S and E. J Intern Med 245 1 (1999) 103-106
153. Tolaymat A., Al Mousily F., MacWilliam K., Lammert N., and Freeman B. Parvovirus glomerulonephritis in a patient with sickle cell disease. Pediatr Nephrol 13 4 (1999) 340-342
154. Koduri P.R., Patel A.R., and Pinar H. Acute hepatic sequestration caused by parvovirus B19 infection in a patient with sickle cell anemia. Am J Hematol 47 3 (1994) 250-251
155. Suell M.N., Horton T.M., Dishop M.K., Mahoney D.H., Olutoye O.O., and Mueller B.U. Outcomes for children with gallbladder abnormalities and sickle cell disease. J Pediatr 145 5 (2004) 617-621
156. Suell M.N., Horton T.M., Dishop M.K., Mahoney D.H., Olutoye O.O., and Mueller B.U. Outcomes for children with gallbladder abnormalities and sickle cell disease. J Pediatr 145 5 (2004) 617-621
157. Antal P., Gauderer M., Koshy M., and Berman B. Is the incidence of appendicitis reduced in patients with sickle cell disease?. Pediatrics 101 1 (1998) E7
158. Suell M.N., Horton T.M., Dishop M.K., Mahoney D.H., Olutoye O.O., and Mueller B.U. Outcomes for children with gallbladder abnormalities and sickle cell disease. J Pediatr 145 5 (2004) 617-621
159. Mantadakis E., Cavender J.D., Rogers Z.R., Ewalt D.H., and Buchanan G.R. Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol 21 6 (1999) 518-522
160. Mantadakis E., Cavender J.D., Rogers Z.R., Ewalt D.H., and Buchanan G.R. Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol 21 6 (1999) 518-522
161. Hakim L., Hasmat A., and Macchia R. Priapism. In: Embury S.H., Hebbel R.P., Mohandas N., and Steinberg M.H. (Eds). Sickle cell disease: basic Principles and clinical practice (1994), Raven Press, New York 633-643
162. Serjeant G.R., de Ceulaer K., and Maude G.H. Stilboestrol and stuttering priapism in homozygous sickle-cell disease. Lancet 2 8467 (1985) 1274-1276
163. Siegel J.F., Rich M.A., and Brock W.A. Association of sickle cell disease, priapism, exchange transfusion and neurological events: ASPEN syndrome. J Urol 150 5 Pt. 1 (1993) 1480-1482
164. Rackoff W.R., Ohene-Frempong K., Month S., Scott J.P., Neahring B., and Cohen A.R. Neurologic events after partial exchange transfusion for priapism in sickle cell disease. J Pediatr 120 6 (1992) 882-885
165. Mantadakis E., Ewalt D.H., Cavender J.D., Rogers Z.R., and Buchanan G.R. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood 95 1 (2000) 78-82
166. Nguyen M.T., Ewalt D.H., Cavender J.D., Buchanan G.F., and Rogers Z.R. Leuprolide therapy in the treatment of sickle cell anemia-associated priapism in adolescents. Blood (2000)
167. Jean-Baptiste G., and De C.K. Osteoarticular disorders of haematological origin. Baillieres Best Pract Res Clin Rheumatol 14 2 (2000) 307-323
168. el-Sabbagh A.M., and Kamel M. Avascular necrosis of temporomandibular joint in sickle cell disease. Clin Rheumatol 8 3 (1989) 393-397
169. Emodi J.I., and Okoye I.J. Vertebral bone collapse in sickle cell disease: a report of two cases. East Afr Med J 78 8 (2001) 445-446
170. Sadat-Ali M., Ammar A., Corea J.R., and Ibrahim A.W. The spine in sickle cell disease. Int Orthop 18 3 (1994) 154-156
171. Serjeant G.R. Sickle cell disease. 2nd Edition (1992), Oxford University Press, New York
172. Ficat R.P. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. J Bone Joint Surg Br 67 1 (1985) 3-9 1985.
173. Adekile A.D., Gupta R., Yacoub F., Sinan T., Al-Bloushi M., and Haider M.Z. Avascular necrosis of the hip in children with sickle cell disease and high Hb F: magnetic resonance imaging findings and influence of alpha-thalassemia trait. Acta Haematol 105 1 (2001) 27-31
174. Ware H.E., Brooks A.P., Toye R., and Berney S.I. Sickle cell disease and silent avascular necrosis of the hip. J Bone Joint Surg Br 73 6 (1991) 947-949
175. Styles L.A., and Vichinsky E.P. Core decompression in avascular necrosis of the hip in sickle-cell disease. Am J Hematol 52 2 (1996) 103-107
176. Milner P.F., Kraus A.P., Sebes J.I., Sleeper L.A., Dukes K.A., Embury S.H., et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med 325 21 (1991) 1476-1481
177. Aguilar C.M., Neumayr L.D., Eggleston B.E., Earles A.N., Robertson S.M., Jergesen H.E., et al. Clinical evaluation of avascular necrosis in patients with sickle cell disease: Children's Hospital Oakland Hip Evaluation Scale-a modification of the Harris Hip Score. Arch Phys Med Rehabil 86 7 (2005) 1369-1375
178. Stulberg B.N., Davis A.W., Bauer T.W., Levine M., and Easley K. Osteonecrosis of the femoral head. A prospective randomized treatment protocol. Clin Orthop Relat Res 268 (1991) 140-151
179. Glickstein M.F., Burk Jr. D.L., Schiebler M.L., Cohen E.K., Dalinka M.K., Steinberg M.E., et al. Avascular necrosis versus other diseases of the hip: sensitivity of MR imaging. Radiology 169 1 (1988) 213-215
180. Coleman B.G., Kressel H.Y., Dalinka M.K., Scheibler M.L., Burk D.L., and Cohen E.K. Radiographically negative avascular necrosis: detection with MR imaging. Radiology 168 2 (1988) 525-528
181. Gupta R., and Adekile A.D. MRI follow-up and natural history of avascular necrosis of the femoral head in Kuwaiti children with sickle cell disease. J Pediatr Hematol Oncol 26 6 (2004) 351-353
182. Zurlo J.V. The double-line sign. Radiology 212 2 (1999) 541-542
183. Neumayr L, Robertson S, Aguilar C, Earles AN, Jergesen HE, Haberkern C, et al. Progression of Avascular Necrosis of the Hip in Sickle Cell Disease: 3 Year Follow-up of Randomized Trial of Aggressive Physical Therapy and Hip Coring Decompression. Program of the 29th Annual Meeting of the National Sickle Cell Disease Program. 2006.
184. Hanker G.J., and Amstutz H.C. Osteonecrosis of the hip in the sickle-cell diseases. Treatment and complications. J Bone Joint Surg Am 70 4 (1988) 499-506
185. Hernigou P., Galacteros F., Bachir D., and Goutallier D. Deformities of the hip in adults who have sickle-cell disease and had avascular necrosis in childhood. A natural history of fifty-two patients. J Bone Joint Surg Am 73 1 (1991) 81-92
186. Milner P.F., Kraus A.P., Sebes J.I., Sleeper L.A., Dukes K.A., Embury S.H., et al. Osteonecrosis of the humeral head in sickle cell disease. Clin Orthop Relat Res 289 (1993) 136-143
187. Serjeant G.R., Ashcroft M.T., and Serjeant B.E. The clinical features of haemoglobin SC disease in Jamaica. Br J Haematol 24 4 (1973) 491-501
188. Gladwin M.T., Sachdev V., Jison M.L., Shizukuda Y., Plehn J.F., Minter K., et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 350 (2004) 886-895
189. De Castro L., Jonassaint J.C., and Graham F.L. Pulmonary hypertension in SS, SC and Sbeta thalassemia: prevalence, associated clinical syndromes, and mortality. Blood 104 (2006) 462a
190. Ambrusko S.J., Gunawardena S., Sakara A., Windsor B., Lanford L., Michelson P., et al. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease. Pediat Blood Cancer (2006) 1-7
191. Suell M.N., Bezold L.I., Okcu F., Mahoney D., Shardonfosky F., and Mueller B.U. Increased pulmonary artery pressures among adolescents with sickle cell disease. J Pediatr Hematol Oncol 27 (2005) 654-658
192. Gladwin M.T., and Kato G.J. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia. Hematology (2005) 51-57
193. Thomas P.W., Singhal A., Hemmings-Kelly M., and Serjeant G.R. Height and weight reference curves for homozygous sickle cell disease. Arch Dis Child 82 3 (2000) 204-208
194. Leonard M.B., Zemel B.S., Kawchak D.A., Ohene-Frempong K., and Stallings V.A. Plasma zinc status, growth, and maturation in children with sickle cell disease. J Pediatr 132 3 Pt. 1 (1998) 467-471
195. Serjeant G.R., Singhal A., and Hambleton I.R. Sickle cell disease and age at menarche in Jamaican girls: observations from a cohort study. Arch Dis Child 85 5 (2001) 375-378
196. Platt O.S., Rosenstock W., and Espeland M.A. Influence of sickle hemoglobinopathies on growth and development. N Engl J Med 311 1 (1984) 7-12
197. Cipolotti R., Caskey M.F., Franco R.P., Mello E.V., Dal Fabbro A.L., Gurgel R.Q., et al. Childhood and adolescent growth of patients with sickle cell disease in Aracaju, Sergipe, north-east Brazil. Ann Trop Paediatr 20 2 (2000) 109-113
198. Nelson M.C., Zemel B.S., Kawchak D.A., Barden E.M., Frongillo Jr. E.A., Coburn S.P., et al. Vitamin B6 status of children with sickle cell disease. J Pediatr Hematol Oncol 24 6 (2002) 463-469
199. Malinauskas B.M., Gropper S.S., Kawchak D.A., Zemel B.S., Ohene-Frempong K., and Stallings V.A. Impact of acute illness on nutritional status of infants and young children with sickle cell disease. J Am Diet Assoc 100 3 (2000) 330-334
200. Fung E.B., Kawchak D.A., Zemel B.S., Ohene-Frempong K., and Stallings V.A. Plasma zinc is an insensitive predictor of zinc status: use of plasma zinc in children with sickle cell disease. Nutr Clin Pract 17 6 (2002) 365-372
201. Buison A.M., Kawchak D.A., Schall J., Ohene-Frempong K., Stallings V.A., and Zemel B.S. Low vitamin D status in children with sickle cell disease. J Pediatr 145 5 (2004) 622-627
202. Barden E.M., Zemel B.S., Kawchak D.A., Goran M.I., Ohene-Frempong K., and Stallings V.A. Total and resting energy expenditure in children with sickle cell disease. J Pediatr 136 1 (2000) 73-79